Contract research and manufacturing services for drug development across discovery to clinical stages
Pharmaron is a China-based CRO and CDMO serving pharma clients across small molecules, biologics, and cell/gene therapies. The hiring mix—research and manufacturing dominate; data and engineering are sparse—reflects a services business structured around wet lab and scale-up delivery rather than platform software. Pain points center on FDA/HIPAA compliance, analytical troubleshooting, and lab efficiency, signaling Pharmaron is investing in operational rigor and regulatory infrastructure as it expands U.S. presence.
Notable leadership hires: Project Director
Pharmaron provides contract research and manufacturing services covering the full drug development lifecycle: discovery chemistry, preclinical pharmacology and toxicology, DMPK, bioanalysis, and clinical-stage manufacturing. The company serves small-molecule, biologic, and cell/gene therapy programs. Established in 2004 and headquartered in Beijing, Pharmaron operates as a private company with 10,000+ employees and is actively scaling U.S. operations, including a new pharmacovigilance team. Current project work includes API process development, analytical method transfer, system validation, and lab efficiency improvements.
Pharmaron provides synthetic chemistry, medicinal chemistry, biology screening, DMPK, pharmacology, toxicology, radiochemistry, CMC services, and clinical development support across discovery through first-in-human studies.
Pharmaron uses Python, SAP, Oracle, GCP, Microsoft 365, and scientific tools including LC-MS, HPLC, Gaussian, PyTorch, TensorFlow, and RDKit for computational chemistry and data analysis.
Other companies in the same industry, closest in size